New surface coatings that enhance hemocompatibility and biofunctionality of synthetic vascular grafts such as expanded poly(tetrafluoroethylene) (ePTFE) and poly(ethylene terephthalate) (PET) are urgently needed. Lubricant‐infused surfaces prevent nontargeted adhesion and enhance the biocompatibility of blood‐contacting surfaces. However, limited success has been made in incorporating biofunctionality onto these surfaces and generating biofunctional lubricant‐infused coatings that both prevent nonspecific adhesion and enhance targeted binding of biomolecules remains a challenge. Here, a new generation of fluorosilanized lubricant‐infused PET surfaces with built‐in biofunctional nanoprobes is reported. These surfaces are synthesized by starting with a self‐assembled monolayer of fluorosilane that is partially etched using plasma modification technique, thereby creating a hydroxyl‐terminated fluorosilanized PET surface. Simultaneously, silanized nanoprobes are produced by amino‐silanizing anti‐CD34 antibody in solution and directly coupling the anti‐CD34‐aminosilane nanoprobes onto the hydroxyl terminated, fluorosilanized PET surface. The PET surfaces are then lubricated, creating fluorosilanized biofunctional lubricant‐infused PET substrates. Compared with unmodified PET surfaces, the designed biofunctional lubricant‐infused PET surfaces significantly attenuate thrombin generation and blood clot formation and promote targeted binding of endothelial cells from human whole blood.